0001209191-22-004415.txt : 20220121
0001209191-22-004415.hdr.sgml : 20220121
20220121161846
ACCESSION NUMBER: 0001209191-22-004415
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220119
FILED AS OF DATE: 20220121
DATE AS OF CHANGE: 20220121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barton Russell
CENTRAL INDEX KEY: 0001867418
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40551
FILM NUMBER: 22546145
MAIL ADDRESS:
STREET 1: C/O ACUMEN PHARMACEUTICALS, INC.
STREET 2: 427 PARK STREET
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acumen Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001576885
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 364108129
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 427 PARK ST.
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
BUSINESS PHONE: 925-368-8508
MAIL ADDRESS:
STREET 1: 427 PARK ST.
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-19
0
0001576885
Acumen Pharmaceuticals, Inc.
ABOS
0001867418
Barton Russell
C/O ACUMEN PHARMACEUTICALS, INC.
427 PARK STREET
CHARLOTTESVILLE
VA
22902
0
1
0
0
Chief Operating Officer
Employee Stock Option (right to buy)
5.19
2022-01-19
4
A
0
135000
0.00
A
2032-01-19
Common Stock
135000
135000
D
Twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on January 19, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest and become exercisable each month thereafter, subject to Reporting Person continuing to provide service through each such date.
/s/ Katie Lapidus, Attorney-in-Fact
2022-01-21